ApprovalTrail

Medical device licence · 21029 · Class 3

RAPIDPOINT COAGULATION SYSTEM

No longer licensed: discontinued at renewal

Licence status Discontinued at renewal; first licensed June 1, 2000; ended October 1, 2004. It is in Health Canada’s archive of licences no longer in force.
Licence number
21029
Licence holder
Bayer Healthcare Llc Subsidiary Of Bayer CorporationMishawaka, IN, United States
Risk class
Class III (moderate to high risk)
Licence type
System
First licensed
June 1, 2000
Ended
October 1, 2004
Devices covered
7

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • RAPIDPOINT COAGULATION SYSTEM - INSTRUMENT
  • RAPIDPOINT COAGULATION SYSTEM - LOW RANGE HEPARIN MANAGEMENT TEST (LHMT)
  • RAPIDPOINT SYSTEM - ACTIVATED PARTIAL THROMBOPLASTIN TIME (APTT)
  • RAPIDPOINT SYSTEM - HEPARIN MANAGEMENT PANEL LEVEL 1 AND 2
  • RAPIDPOINT SYSTEM - HEPARIN MONITORING TIME (HMT)
  • RAPIDPOINT SYSTEM - PROTHROMBIN (PT)
  • RAPIDPOINT SYSTEM - PT-NC (PROTHROMBIN ON NON CITRATED WHOLE BLOOD)

Recalls and safety alerts that mention it

Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “rapidpoint”. A notice may cover another product or only some lots: read it to see what it covers.

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.